AKT1 and colorectal carcinoma: In the present study, we investigated whether calcium-mediated deactivation of FAK led to the inhibition of Akt signaling, bypassing the inhibitory pathway of RAF family kinases by sorafenib, and resulting in an enhanced antitumor effect on CRC cells.